Integrated BioPharma, Inc.
INBP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.59M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.59 Million |
|---|---|
| Enterprise Value | $4.20 Million |
| Earnings per Share | $-0.09 |
| Beta | 0.4 |
| Outstanding Shares | 31,059,610 |
Return
| Return on Equity | -16.09% |
|---|---|
| Return on Assets | -11.22% |
| Return on Invested Capital | -13.68% |
Valuation & Multiples
| P/E Ratio | -1.97 |
|---|---|
| PEG | -0.29 |
| Price to Sales | 0.17 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | -1.57 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.73 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 25, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Integrated BioPharma, Inc.
134 employees
CEO: Riva Sheppard
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The compa...